• Industry Briefs June 2017

    Industry Briefs by and on June 16th, 2017

    Tobacco Deaths are Responsible in Poor U.S. Health Ranking According to the report, Tobacco in America: Leaving the Vulnerable Behind, released by Action on Smoking and Health (ASA), “…tobacco remains the number #1 cause of preventable death in America, accounting for 1 in 5 deaths, and costs the U.S. economy more than $300 billion per […]

  • Industry Briefs May 2017

    Industry Briefs by on May 22nd, 2017

    Group Aims to Decrease Stuttering Stigma Millions of Americans who stutter live within a “vocal prison,” according to the American Institute of Stuttering (AIS), which recently held its first National Stuttering Awareness week. Their goal is to raise awareness of stuttering to destigmatize the condition and help those who see stuttering as a joke or […]

  • Industry Briefs April 2017

    Industry Briefs by on April 10th, 2017

    Veeva and QuintilesIMS Trade Lawsuits After three years of negotiation attempts, QuintilesIMS and Veeva have traded lawsuits. Most recently, Veeva filed a countersuit against the company for violations of federal and state antitrust and unfair competition laws. The company alleges that actions taken by QuintilesIMS—notably the company’s refusal to allow customers to load its customer […]

  • Industry Briefs March 2017

    Industry Briefs by on March 17th, 2017

    U.S. Lawmakers Call Out Marathon Pharmaceuticals on Pricing U.S. Representative Elijah Cummings and Senator Bernie Sanders recently asked Marathon to justify its $54,000 a year (after discounts) drugs, including Emflaza, a treatment for Duchenne muscular dystrophy, according to the Washington Post. The politicians want Marathon to disclose development costs, show how the price was set, […]

  • Industry Briefs February 2017

    Industry Briefs by on February 24th, 2017

    CVS Offers Low-cost Generic EpiPen CVS, the largest drug-store chain in the U.S., has added to the EpiPen controversy by launching its own generic version of the Mylan-manufactured epinephrine/auto-injection system for life-threatening anaphylactic emergencies. The high cost of Mylan’s brand name product, which health insurer Cigna recently announced it would not cover the full cost […]

  • Industry Briefs January 2017

    Industry Briefs by on January 18th, 2017

    Wealthy Philanthropists to Drastically Change Drug Research Facebook founder Mark Zuckerberg and his wife Priscilla Chan want to “cure, prevent, or manage all disease” by the end of the century—and they are not alone. Philanthropists such as Facebook’s former president Sean Parker, Citigroup former CEO Sandy Weill, and Nike co-founder Phil Knight, are all funding […]

  • Industry Briefs December 2016

    Industry Briefs by and on December 21st, 2016

    ACA Repeal in Question as New Administration Emerges President-elect Donald Trump made clear throughout his campaign that one of his most immediate goals would be the repeal of the Affordable Care Act. While many believe he won’t be able to easily repeal the ACA, he can, according to Reuters, without Congressional approval, make massive changes […]

  • Industry Briefs November 2016

    Industry Briefs by on November 23rd, 2016

    Deep Cuts Rock Novo Nordisk as CEO Steps Down One thousand cuts to staff are in the works at Novo Nordisk. According to company officials, the cuts are necessary to sustain productivity in 2017 as the company faces challenges and competitors. The notices will be distributed within the next two months. The cuts include: R&D […]

  • Industry Briefs October 2016

    Industry Briefs by and on October 31st, 2016

    Controversy Surrounding Mylan’s EpiPen Heather Bresch, CEO of Mylan, testified before the U.S. House Committee in late September to address the price hike of the EpiPen. Criticism from the public and lawmakers surrounding Mylan epinephrine injectors reached an all-time high in August. Since acquiring the EpiPen in 2007, Mylan raised the price of a two-pack […]

  • Industry Briefs September 2016

    Industry Briefs by on September 15th, 2016

    Shire and Jennifer Aniston partner on Eyelove Eyelove has emerged after the partnership between Jennifer Aniston and Shire plc. The educational campaign is intended to shine light on chronic dry eye, which affects over 16 million adults in the United States, most commonly affecting women and older people. Commonly reported symptoms include burning, itchy, stinging […]

  • Industry Briefs August 2016

    Industry Briefs by on August 23rd, 2016

    Medtronic Plans to Expand Heart Failure Portfolio After acquiring HeartWare International, Inc. for $1.1 million, Medtronic recently announced that it plans to expand its portfolio of diagnostics tools, therapies, and services for patients suffering from heart failure. Among other products, HeartWare designed the world’s smallest full support ventricular assist device (VAD)—its flagship product—to reduce surgical […]

  • Industry Briefs June 2016

    Industry Briefs by on June 20th, 2016

    Practice Fusion Founder and Former CEO Launches New Wearables Company iBeat is a new Wearables-as-a-Service company dedicated to extending lifespan recently launched by Ryan Howard, Founder and former CEO of Practice Fusion. According to Howard, iBeat now offers a groundbreaking, heart-monitoring smartwatch called the iBeat Life Monitor and is said to be a literal lifesaver […]

  • Industry Briefs May 2016

    Industry Briefs by and on May 25th, 2016

    Two Former Agency Presidents Launch Elevate Healthcare Frank X. Powers, the former President of Dudnyk, and Lorna Weir, a former president at both Dudnyk and Vox Medica as well as the principal of her own consulting firm, have teamed up to launch Elevate Healthcare. The new venture is a multidisciplinary strategy lab, based in suburban […]

Back to top